AFL
Aflac Incorporated
Price Chart
Latest Quote
$111.95
Current Price| Previous Close | $110.95 |
| Open | $111.50 |
| Day High | $112.10 |
| Day Low | $110.28 |
| Volume | 2,327,420 |
Stock Information
| Quarterly Dividend / Yield | $2.44 / 2.18% |
| Shares Outstanding | 524.11M |
| Total Debt | $14.34B |
| Cash Equivalents | $9.13B |
| Revenue | $17.70B |
| Net Income | $4.17B |
| Sector | Financial Services |
| Industry | Insurance - Life |
| Market Cap | $59.87B |
| P/E Ratio | 14.71 |
| EPS (TTM) | $7.61 |
| Exchange | NYQ |
📊 Custom Metrics & Score
Score: 10/42| Debt to Equity | 0.29 |
| Debt to Earnings | 1.17 |
| Avg Revenue Growth | -2.81% |
| Profit Margin | 28.46% |
| Return on Equity | 20.86% |
| Avg FCF Growth | -11.60% |
| FCF Yield | 4.52% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $111.95 | 2,327,420 |
| 2026-01-30 | $110.95 | 3,669,900 |
| 2026-01-29 | $110.51 | 2,490,300 |
| 2026-01-28 | $108.92 | 1,637,600 |
| 2026-01-27 | $108.38 | 2,300,500 |
| 2026-01-26 | $108.94 | 1,533,200 |
| 2026-01-23 | $107.09 | 1,859,200 |
| 2026-01-22 | $108.30 | 2,068,700 |
| 2026-01-21 | $108.56 | 2,493,200 |
| 2026-01-20 | $109.26 | 2,398,300 |
| 2026-01-16 | $109.51 | 6,139,900 |
| 2026-01-15 | $109.61 | 2,138,100 |
| 2026-01-14 | $110.18 | 2,173,600 |
| 2026-01-13 | $107.96 | 1,942,600 |
| 2026-01-12 | $108.88 | 1,486,000 |
| 2026-01-09 | $109.24 | 1,721,000 |
| 2026-01-08 | $110.26 | 2,004,700 |
| 2026-01-07 | $110.19 | 1,339,600 |
| 2026-01-06 | $111.96 | 2,211,900 |
| 2026-01-05 | $112.19 | 1,961,800 |
About Aflac Incorporated
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its products through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is based in Columbus, Georgia.
📰 Latest News
January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week
Yahoo Finance • 2026-02-01T12:47:23ZAflac Gears Up for Q4 Earnings: Can Higher Premiums Help it Quack?
Zacks • 2026-02-02T14:42:00Z
Reassessing Aflac (AFL) Valuation After Strong Multi Year Returns And Mixed Fair Value Signals
Simply Wall St. • 2026-02-01T17:09:59Z
Countdown to Aflac (AFL) Q4 Earnings: Wall Street Forecasts for Key Metrics
Zacks • 2026-01-30T14:15:03Z
Unum (UNM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks • 2026-01-29T15:00:14Z
Aflac (AFL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks • 2026-01-28T15:00:04Z
Those who invested in Aflac (NYSE:AFL) five years ago are up 166%
Simply Wall St. • 2026-01-24T12:00:11Z
Here’s How Much Money Americans Say They Need to Feel Financially Secure—Does Yours Match?
Investopedia • 2026-01-24T12:00:00Z
3 Insurance Stocks with Questionable Fundamentals
StockStory • 2026-01-20T04:35:57Z
A Fresh Look At Aflac (AFL) Valuation As Long Term Returns Contrast With Muted Recent Performance
Simply Wall St. • 2026-01-17T04:18:18Z
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue | $19,128,000,000 | $18,841,000,000 | $19,151,000,000 | $21,546,000,000 |
| Operating Revenue | $19,128,000,000 | $18,841,000,000 | $19,151,000,000 | $21,546,000,000 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $197,000,000 | $195,000,000 | $226,000,000 | $238,000,000 |
| Total Expenses | $12,711,000,000 | $13,579,000,000 | $14,282,000,000 | $16,338,000,000 |
| Other Income Expense | $100,000,000 | $177,000,000 | $220,000,000 | $173,000,000 |
| Net Non Operating Interest Income Expense | $-197,000,000 | $-195,000,000 | $-226,000,000 | $-238,000,000 |
| Interest Expense Non Operating | $197,000,000 | $195,000,000 | $226,000,000 | $238,000,000 |
| Other Operating Expenses | $201,000,000 | $140,000,000 | $11,000,000 | $-8,000,000 |
| Loss Adjustment Expense | $10,464,000,000 | $11,376,000,000 | $12,136,000,000 | $14,017,000,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $5,443,000,000 | $4,659,000,000 | $4,418,000,000 | $4,231,000,000 |
| Net Interest Income | $-197,000,000 | $-195,000,000 | $-226,000,000 | $-238,000,000 |
| Normalized Income | $5,443,000,000 | $4,659,000,000 | $4,418,000,000 | $4,231,000,000 |
| Net Income From Continuing And Discontinued Operation | $5,443,000,000 | $4,659,000,000 | $4,418,000,000 | $4,231,000,000 |
| Net Income Common Stockholders | $5,443,000,000 | $4,659,000,000 | $4,418,000,000 | $4,231,000,000 |
| Net Income | $5,443,000,000 | $4,659,000,000 | $4,418,000,000 | $4,231,000,000 |
| Net Income Including Noncontrolling Interests | $5,443,000,000 | $4,659,000,000 | $4,418,000,000 | $4,231,000,000 |
| Net Income Continuous Operations | $5,443,000,000 | $4,659,000,000 | $4,418,000,000 | $4,231,000,000 |
| Pretax Income | $6,417,000,000 | $5,262,000,000 | $4,869,000,000 | $5,208,000,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $9.63 | $7.78 | $6.93 | $6.39 |
| Basic EPS | $9.68 | $7.81 | $6.96 | $6.42 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| EBIT | $6,614,000,000 | $5,457,000,000 | $5,095,000,000 | $5,446,000,000 |
| Diluted Average Shares | $565,015,000 | $598,745,000 | $637,655,000 | $676,729,000 |
| Basic Average Shares | $562,492,000 | $596,173,000 | $634,816,000 | $673,617,000 |
| Diluted NI Availto Com Stockholders | $5,443,000,000 | $4,659,000,000 | $4,418,000,000 | $4,231,000,000 |
| Tax Provision | $974,000,000 | $603,000,000 | $451,000,000 | $977,000,000 |
| Net Policyholder Benefits And Claims | $10,464,000,000 | $11,376,000,000 | $12,136,000,000 | $14,017,000,000 |
| Policyholder Benefits Gross | - | - | $12,758,000,000 | $14,504,000,000 |
| Policyholder Benefits Ceded | - | - | $355,000,000 | $384,000,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $26,098,000,000 | $21,985,000,000 | $20,140,000,000 | $33,253,000,000 |
| Total Assets | $117,566,000,000 | $126,724,000,000 | $131,738,000,000 | $157,542,000,000 |
| Receivables | $779,000,000 | $848,000,000 | $647,000,000 | $672,000,000 |
| Loans Receivable | $4,430,000,000 | $4,704,000,000 | $5,203,000,000 | $4,523,000,000 |
| Accounts Receivable | $779,000,000 | $848,000,000 | $647,000,000 | $672,000,000 |
| Cash Cash Equivalents And Short Term Investments | $71,498,000,000 | $77,596,000,000 | $79,684,000,000 | $103,747,000,000 |
| Cash And Cash Equivalents | $6,229,000,000 | $4,306,000,000 | $3,943,000,000 | $5,051,000,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Debt | $1,173,000,000 | $2,934,000,000 | $3,352,000,000 | $2,788,000,000 |
| Total Debt | $7,498,000,000 | $7,364,000,000 | $7,442,000,000 | $7,956,000,000 |
| Long Term Debt And Capital Lease Obligation | $7,498,000,000 | $7,364,000,000 | $7,442,000,000 | $7,956,000,000 |
| Long Term Debt | $7,402,000,000 | $7,240,000,000 | $7,295,000,000 | $7,839,000,000 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Minimum Pension Liabilities | $10,000,000 | $-8,000,000 | $-36,000,000 | $-166,000,000 |
| Total Liabilities Net Minority Interest | $91,468,000,000 | $104,739,000,000 | $111,598,000,000 | $124,289,000,000 |
| Payables And Accrued Expenses | $573,000,000 | $154,000,000 | $698,000,000 | $4,339,000,000 |
| Payables | $573,000,000 | $154,000,000 | $698,000,000 | $4,339,000,000 |
| Total Tax Payable | $573,000,000 | $154,000,000 | $698,000,000 | $4,339,000,000 |
| Income Tax Payable | $573,000,000 | $154,000,000 | $698,000,000 | $4,339,000,000 |
| Other Payable | - | - | $1,809,000,000 | $2,162,000,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $26,098,000,000 | $21,985,000,000 | $20,140,000,000 | $33,253,000,000 |
| Total Equity Gross Minority Interest | $26,098,000,000 | $21,985,000,000 | $20,140,000,000 | $33,253,000,000 |
| Stockholders Equity | $26,098,000,000 | $21,985,000,000 | $20,140,000,000 | $33,253,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-2,978,000,000 | $-5,520,000,000 | $-6,429,000,000 | $7,393,000,000 |
| Other Equity Adjustments | $2,006,000,000 | $-2,560,000,000 | $-2,100,000,000 | - |
| Retained Earnings | $52,277,000,000 | $47,993,000,000 | $44,367,000,000 | $41,381,000,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Treasury Shares Number | $806,799,000 | $776,919,000 | $738,823,000 | $700,607,000 |
| Ordinary Shares Number | $549,964,000 | $578,479,000 | $615,256,000 | $652,132,000 |
| Share Issued | $1,356,763,000 | $1,355,398,000 | $1,354,079,000 | $1,352,739,000 |
| Tangible Book Value | $26,098,000,000 | $21,985,000,000 | $20,140,000,000 | $33,253,000,000 |
| Invested Capital | $33,500,000,000 | $29,225,000,000 | $27,435,000,000 | $41,092,000,000 |
| Capital Lease Obligations | $96,000,000 | $124,000,000 | $147,000,000 | $117,000,000 |
| Total Capitalization | $33,500,000,000 | $29,225,000,000 | $27,435,000,000 | $41,092,000,000 |
| Foreign Currency Translation Adjustments | $-4,998,000,000 | $-4,069,000,000 | $-3,564,000,000 | $-2,013,000,000 |
| Unrealized Gain Loss | $4,000,000 | $1,117,000,000 | $-729,000,000 | $9,572,000,000 |
| Treasury Stock | $26,231,000,000 | $23,395,000,000 | $20,574,000,000 | $18,185,000,000 |
| Additional Paid In Capital | $2,894,000,000 | $2,771,000,000 | $2,641,000,000 | $2,529,000,000 |
| Capital Stock | $136,000,000 | $136,000,000 | $135,000,000 | $135,000,000 |
| Common Stock | $136,000,000 | $136,000,000 | $135,000,000 | $135,000,000 |
| Long Term Capital Lease Obligation | $96,000,000 | $124,000,000 | $147,000,000 | $117,000,000 |
| Investments And Advances | $82,031,000,000 | $92,197,000,000 | $95,888,000,000 | $122,299,000,000 |
| Net PPE | $387,000,000 | $445,000,000 | $530,000,000 | $538,000,000 |
| Other Short Term Investments | $65,269,000,000 | $73,290,000,000 | $75,741,000,000 | $98,696,000,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $2,707,000,000 | $3,190,000,000 | $3,879,000,000 | $5,051,000,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $2,707,000,000 | $3,190,000,000 | $3,879,000,000 | $5,051,000,000 |
| Cash Flow From Continuing Operating Activities | $2,707,000,000 | $3,190,000,000 | $3,879,000,000 | $5,051,000,000 |
| Operating Gains Losses | $-1,835,000,000 | $-1,261,000,000 | $-1,525,000,000 | $-1,265,000,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Investing Cash Flow | $2,781,000,000 | $817,000,000 | $-1,540,000,000 | $-2,378,000,000 |
| Cash Flow From Continuing Investing Activities | $2,781,000,000 | $817,000,000 | $-1,540,000,000 | $-2,378,000,000 |
| Net Other Investing Changes | $841,000,000 | $-550,000,000 | $-561,000,000 | $1,552,000,000 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repurchase Of Capital Stock | $-2,800,000,000 | $-2,801,000,000 | $-2,401,000,000 | $-2,301,000,000 |
| Issuance Of Capital Stock | $14,000,000 | $17,000,000 | $17,000,000 | $26,000,000 |
| Financing Cash Flow | $-3,486,000,000 | $-3,723,000,000 | $-3,551,000,000 | $-2,739,000,000 |
| Cash Flow From Continuing Financing Activities | $-3,486,000,000 | $-3,723,000,000 | $-3,551,000,000 | $-2,739,000,000 |
| Net Other Financing Charges | $-242,000,000 | $-177,000,000 | $-49,000,000 | $-62,000,000 |
| Cash Dividends Paid | $-1,087,000,000 | $-966,000,000 | $-979,000,000 | $-855,000,000 |
| Common Stock Dividend Paid | $-1,087,000,000 | $-966,000,000 | $-979,000,000 | $-855,000,000 |
| Net Common Stock Issuance | $-2,786,000,000 | $-2,784,000,000 | $-2,384,000,000 | $-2,275,000,000 |
| Common Stock Issuance | $14,000,000 | $17,000,000 | $17,000,000 | $26,000,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Repayment Of Debt | $-194,000,000 | $0 | $-1,416,000,000 | $-700,000,000 |
| Issuance Of Debt | $823,000,000 | $204,000,000 | $1,277,000,000 | $1,153,000,000 |
| Interest Paid Supplemental Data | $180,000,000 | $185,000,000 | $211,000,000 | $213,000,000 |
| Income Tax Paid Supplemental Data | $1,367,000,000 | $1,569,000,000 | $961,000,000 | $880,000,000 |
| End Cash Position | $6,229,000,000 | $4,306,000,000 | $3,943,000,000 | $5,051,000,000 |
| Beginning Cash Position | $4,306,000,000 | $3,943,000,000 | $5,051,000,000 | $5,141,000,000 |
| Effect Of Exchange Rate Changes | $-79,000,000 | $79,000,000 | $104,000,000 | $-24,000,000 |
| Changes In Cash | $2,002,000,000 | $284,000,000 | $-1,212,000,000 | $-66,000,000 |
| Common Stock Payments | $-2,800,000,000 | $-2,801,000,000 | $-2,401,000,000 | $-2,301,000,000 |
| Net Issuance Payments Of Debt | $629,000,000 | $204,000,000 | $-139,000,000 | $453,000,000 |
| Net Long Term Debt Issuance | $629,000,000 | $204,000,000 | $-139,000,000 | $453,000,000 |
| Long Term Debt Payments | $-194,000,000 | $0 | $-1,416,000,000 | $-700,000,000 |
| Long Term Debt Issuance | $823,000,000 | $204,000,000 | $1,277,000,000 | $1,153,000,000 |
| Net Investment Purchase And Sale | $881,000,000 | $722,000,000 | $728,000,000 | $-2,747,000,000 |
| Sale Of Investment | $7,990,000,000 | $4,297,000,000 | $4,991,000,000 | $4,624,000,000 |
| Purchase Of Investment | $-7,109,000,000 | $-3,575,000,000 | $-4,263,000,000 | $-7,371,000,000 |
| Change In Working Capital | $-644,000,000 | $-1,652,000,000 | $222,000,000 | $942,000,000 |
| Change In Payables And Accrued Expense | $-393,000,000 | $-967,000,000 | $-509,000,000 | $96,000,000 |
| Change In Payable | $-393,000,000 | $-967,000,000 | $-509,000,000 | $96,000,000 |
| Change In Tax Payable | $-393,000,000 | $-967,000,000 | $-509,000,000 | $96,000,000 |
| Change In Income Tax Payable | $-393,000,000 | $-967,000,000 | $-509,000,000 | $96,000,000 |
| Change In Receivables | $51,000,000 | $-133,000,000 | $5,000,000 | $72,000,000 |
| Other Non Cash Items | $-415,000,000 | $1,183,000,000 | $-125,000,000 | $566,000,000 |
| Amortization Of Securities | $-205,000,000 | $-270,000,000 | $-262,000,000 | $-228,000,000 |
| Gain Loss On Investment Securities | $462,000,000 | $-85,000,000 | $341,000,000 | $-195,000,000 |
| Net Foreign Currency Exchange Gain Loss | $-2,297,000,000 | $-1,176,000,000 | $-1,866,000,000 | $-1,070,000,000 |
| Net Income From Continuing Operations | $5,443,000,000 | $4,659,000,000 | $4,418,000,000 | $4,231,000,000 |